Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP12 | P39900 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | FABP7 | O15540 | 1/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL188404 | 1.00 | EPHX1 (0.44) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL695835 | 0.98 | EPHX1 (0.41) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL697833 | 0.94 | EPHX1 (0.37) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL9034845 | 0.89 | — | — | |
| SCHEMBL8579936 | 0.84 | EPHX1 (0.42) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL1559459 | 0.84 | EPHX1 (0.42) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL5245472 | 0.82 | EPHX1 (0.39) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL2901152 | 0.81 | NAAA (0.40) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL6007716 | 0.81 | EPHX1 (0.46) | EPHX1HTTCYP2C19NAAACYP19A1 | |
| SCHEMBL6007723 | 0.81 | EPHX1 (0.46) | EPHX1HTTCYP2C19NAAACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008065408-A9 | MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS | HUNTER-FLEMING LIMITED (GB) | 2011-03-03 | — | — | WO | disclosed |
| EP-2097079-A2 | MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS | Hunter-Fleming Limited (GB) | 2009-09-09 | — | — | EP | disclosed |
| WO-2008065408-A2 | MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS | HUNTER-FLEMING LIMITED (GB) | 2008-06-05 | — | — | WO | disclosed |
| EP-1848426-A2 | TRICYCLIC CYTOPROTECTIVE COMPOUNDS | Hunter-Fleming Limited (GB) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006082409-A2 | TRICYCLIC CYTOPROTECTIVE COMPOUNDS | HUNTER-FLEMING LIMITED (GB) | 2006-08-10 | — | — | WO | disclosed |
| EP-0721454-A1 | NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST | J. URIACH & CIA. S.A. (ES) | 1996-07-17 | — | — | EP | disclosed |